Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOLSIDOMINE: 383 Adverse Event Reports & Safety Profile

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy
383
Total FAERS Reports
100 (26.1%)
Deaths Reported
200
Hospitalizations
383
As Primary/Secondary Suspect
122
Life-Threatening

First Report: 1990 · Latest Report: 20250416

What Are the Most Common MOLSIDOMINE Side Effects?

#1 Most Reported
Toxic epidermal necrolysis
84 reports (21.9%)
#2 Most Reported
Blister
54 reports (14.1%)
#3 Most Reported
Erythema
53 reports (13.8%)

All MOLSIDOMINE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Toxic epidermal necrolysis 84 21.9% 46 38
Blister 54 14.1% 30 30
Erythema 53 13.8% 30 30
Nausea 48 12.5% 36 35
Multiple organ dysfunction syndrome 45 11.8% 45 37
Respiratory disorder 44 11.5% 44 36
Diarrhoea 41 10.7% 37 40
Hypertension 37 9.7% 19 23
Cholecystitis 36 9.4% 36 35
Electrolyte imbalance 36 9.4% 36 35
Hyperthyroidism 36 9.4% 36 36
Cholelithiasis 33 8.6% 33 33
Restlessness 32 8.4% 32 31
Condition aggravated 31 8.1% 29 29
Dermatitis exfoliative 30 7.8% 30 30
Fall 27 7.1% 17 27
Skin disorder 27 7.1% 17 27
Conjunctivitis 26 6.8% 0 0
Urinary tract infection 26 6.8% 17 17
Hypotension 24 6.3% 0 24

Who Reports MOLSIDOMINE Side Effects? Age & Gender Data

Gender: 61.9% female, 38.1% male. Average age: 73.5 years. Most reports from: DE. View detailed demographics →

Is MOLSIDOMINE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 22 0 0
2001 42 42 36
2007 3 0 3
2008 3 0 2
2009 5 0 5
2012 10 2 8
2014 1 0 1
2015 8 1 8
2016 8 1 6
2017 4 0 1
2018 29 7 4
2019 29 15 20
2020 14 0 14
2021 2 0 2
2022 1 1 0
2023 12 9 3
2024 22 0 8
2025 1 0 1

View full timeline →

What Is MOLSIDOMINE Used For?

IndicationReports
Product used for unknown indication 141
Coronary artery disease 95
Angina pectoris 41
Systemic lupus erythematosus 17
Myocardial infarction 9
Myocardial ischaemia 9
Prescription drug used without a prescription 9
Cardiovascular event prophylaxis 6
Intentional overdose 6

MOLSIDOMINE vs Alternatives: Which Is Safer?

MOLSIDOMINE vs MOMELOTINIB MOLSIDOMINE vs MOMETASONE MOLSIDOMINE vs MOMETASONE FUROATE MOLSIDOMINE vs MOMETASONE FUROATE\OLOPATADINE MOLSIDOMINE vs MONOMETHYL MOLSIDOMINE vs MONTELUKAST MOLSIDOMINE vs MONTELUKAST\MONTELUKAST MOLSIDOMINE vs MONTMORILLONITE MOLSIDOMINE vs MORNIFLUMATE MOLSIDOMINE vs MOROCTOCOG ALFA

Official FDA Label for MOLSIDOMINE

Official prescribing information from the FDA-approved drug label.